GOLDILOCKS THERAPEUTICS
Goldilocks Therapeutics develop preventatives treatments for acute kidney injury, polycystic kidney disease, and other kidney conditions. The company uses its proprietary mesoscale nanoparticles (MNPs) specifically target therapeutic payloads to the renal tubule epithelium. It was founded in 2018 and is based in Bedford, New York.
GOLDILOCKS THERAPEUTICS
Industry:
Health Care Health Diagnostics Medical Wellness
Founded:
2018-01-01
Address:
Bedford, New York, United States
Country:
United States
Website Url:
http://www.goldilockstherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(914) 205-3862
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Edgar A. Jaimes
Edgar A. Jaimes Co-Founder and Chief Medical Officer @ Goldilocks Therapeutics Co-Founder and Chief Medical Officer
Daniel A. Heller
Daniel A. Heller Co-Founder and Chief Scientific Officer @ Goldilocks Therapeutics Co-Founder and Chief Scientific Officer
Arthur Klausner
Arthur Klausner Co-founder, President, CEO @ Goldilocks Therapeutics Co-founder, President, CEO
Founder
Arthur Klausner
Daniel A. Heller
Edgar A. Jaimes
Investors List
Accelerate New York Seed Fund
Accelerate New York Seed Fund investment in Seed Round - Goldilocks Therapeutics
Official Site Inspections
http://www.goldilockstherapeutics.com Semrush global rank: 5.82 M Semrush visits lastest month: 1.43 K
- Host name: 104.21.80.3
- IP address: 104.21.80.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...